Genomictree

Genomictree is a biotech company in South Korea, founded in 2000. It has raised $51.5M across 2 rounds, most recently a $4.0M Venture Round in August 2021.

Founded
2000
Business Model
B2B
Total Funding
$51.5M
Last Round
$4.0M Venture RoundAug 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Genomictree develops non-invasive molecular diagnostics for early cancer detection and multiplex detection of infectious diseases. The company identifies DNA methylation biomarker candidates through a genomic-scale discovery tool and develops methylation biomarkers using sensitive methylation-detection technology. Its proprietary Allele Specific Reactive Primer (ASRP)-mediated PCR and Linear Target Enrichment (LTE) platforms enable liquid-biopsy tests from bodily fluids and multiplex PCR assays that identify multiple human pathogens in clinical specimens. Genomictree commercializes products such as EarlyTect Colon Cancer and aims to enter the global market as a leading company in early cancer diagnosis.

Summary

It has raised $51.5M in total across 2 rounds, most recently a $4.0M Venture Round in Aug 2021. Investors include Orion Capital Asia, KB Investment and Mirae Asset Venture Investment.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundAug 2021
$4.0M

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth EquityTotal funding$1.5BApr 2025
PacBioIPO

Developer and manufacturer of high-accuracy long-read DNA sequencing systems and consumables for ...

USA, United States501–1000Biotech, Genomics
ConvertibleTotal funding$1.2BFeb 2021
Foundation MedicineAcquired

Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...

Cambridge, United States1001–5000Diagnostics, Genomics
Corporate RoundTotal funding$1.1BJan 2015
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Genomictree on Indexed.vc
<a href="https://indexed.vc/companies/genomictree"><img src="https://indexed.vc/api/badge/company/genomictree" alt="Genomictree on Indexed.vc" width="260" height="76" /></a>